215 related articles for article (PubMed ID: 16936386)
1. Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
Krishnan S; Mathuranath PS; Sarma S; Kishore A
Neurol India; 2006 Sep; 54(3):268-72. PubMed ID: 16936386
[TBL] [Abstract][Full Text] [Related]
2. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
4. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
5. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
[TBL] [Abstract][Full Text] [Related]
6. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
Malkiewicz JJ; Siuda J
Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
[TBL] [Abstract][Full Text] [Related]
7. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
[TBL] [Abstract][Full Text] [Related]
8. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.
Kass-Iliyya L; Kobylecki C; McDonald KR; Gerhard A; Silverdale MA
Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161
[TBL] [Abstract][Full Text] [Related]
9. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
10. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid levels in Parkinson's disease and related disorders.
Sakuta H; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Watanabe Y; Hirata K
Brain Behav; 2017 Jan; 7(1):e00598. PubMed ID: 28127516
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
Soliveri P; Monza D; Paridi D; Carella F; Genitrini S; Testa D; Girotti F
J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
[TBL] [Abstract][Full Text] [Related]
13. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).
Bak TH; Crawford LM; Hearn VC; Mathuranath PS; Hodges JR
Neurocase; 2005 Aug; 11(4):268-73. PubMed ID: 16093227
[TBL] [Abstract][Full Text] [Related]
14. A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
De Pablo-Fernández E; Courtney R; Warner TT; Holton JL
JAMA Neurol; 2018 Aug; 75(8):1008-1012. PubMed ID: 29710120
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy.
Deguchi K; Sasaki I; Tsukaguchi M; Kamoda M; Touge T; Takeuchi H; Kuriyama S
J Neurol Sci; 2002 Jul; 199(1-2):31-7. PubMed ID: 12084439
[TBL] [Abstract][Full Text] [Related]
16. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
[TBL] [Abstract][Full Text] [Related]
17. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of parkinsonian syndromes according to differences in executive functions.
Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
[TBL] [Abstract][Full Text] [Related]
19. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
Kim KJ; Jeong SJ; Kim JM
Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
[TBL] [Abstract][Full Text] [Related]
20. Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.
Paviour DC; Winterburn D; Simmonds S; Burgess G; Wilkinson L; Fox NC; Lees AJ; Jahanshahi M
Neurocase; 2005 Aug; 11(4):274-82. PubMed ID: 16093228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
